申请人:Hoechst-Roussel Pharmaceuticals Inc.
公开号:US04335122A1
公开(公告)日:1982-06-15
The invention relates to diuretic dihydro-dibenzoxepines-thiepines and -morphanthridones of the formula ##STR1## wherein R is ##STR2## where R.sup.4 is a hydrogen or an alkyl; R.sup.1 is hydrogen or alkyl; R.sup.2 and R.sup.3 are the same or different and are hydrogen, alkyl or R.sup.2 and R.sup.3 are fused to form a pyrrolidino, morpholino, piperidino or azepino ring substituent; Y is hydrogen, halogen and alkoxy, X is ##STR3## where R.sup.4 is as defined above; m is an integer of 0 or 1; and n is an integer of 2 or 3; and the pharmaceutically acceptable acid addition salts thereof.
该发明涉及利尿剂二氢-二苯氧基-噻吩和-吖啶酮的化合物,其化学式为##STR1##其中R为##STR2##其中R.sup.4为氢或烷基;R.sup.1为氢或烷基;R.sup.2和R.sup.3相同或不同,为氢、烷基或R.sup.2和R.sup.3融合形成吡咯啉、吗啉、哌啶或氮杂七元环取代基;Y为氢、卤素和烷氧基,X为##STR3##其中R.sup.4如上定义;m为0或1的整数;n为2或3的整数;以及其药用可接受的酸盐。